92 related articles for article (PubMed ID: 2866753)
21. Alterations in brain dopamine and GABA following inorganic or organic manganese administration.
Gianutsos G; Murray MT
Neurotoxicology; 1982 Nov; 3(3):75-81. PubMed ID: 6891761
[TBL] [Abstract][Full Text] [Related]
22. Biological markers in mental disorders: post-mortem studies.
Rossor M
J Psychiatr Res; 1984; 18(4):457-65. PubMed ID: 6150994
[TBL] [Abstract][Full Text] [Related]
23. Striatal dopamine depletion, dopamine receptor stimulation, and GABA metabolism: implications for the therapy of Parkinson's disease.
Bennett JP
Ann Neurol; 1986 Feb; 19(2):194-7. PubMed ID: 3083762
[TBL] [Abstract][Full Text] [Related]
24. [The metabolically disordered neuron].
Woelk H
Med Klin; 1979 Oct; Suppl():6-9. PubMed ID: 44343
[No Abstract] [Full Text] [Related]
25. Biochemistry of the basal ganglia.
Fahn S
Adv Neurol; 1976; 14():59-89. PubMed ID: 7932
[No Abstract] [Full Text] [Related]
26. [The antipsychotic action of neuroleptics and basal ganglia function].
Arushanian EB
Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
[No Abstract] [Full Text] [Related]
27. Progressive supranuclear palsy.
Morgan OS; Cawich F; Cruickshank JK
West Indian Med J; 1982 Sep; 31(3):156-8. PubMed ID: 7179941
[No Abstract] [Full Text] [Related]
28. Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced parkinsonism.
Kito S; Miyoshi R; Mizuno K; Nitta K; Matsubayashi H; Yamamura Y; Tahara E
Adv Neurol; 1987; 45():159-65. PubMed ID: 2881441
[No Abstract] [Full Text] [Related]
29. Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA.
Vihavainen T; Relander TR; Leiviskä R; Airavaara M; Tuominen RK; Ahtee L; Piepponen TP
J Neurochem; 2008 Nov; 107(3):844-54. PubMed ID: 18786163
[TBL] [Abstract][Full Text] [Related]
30. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
Carlsson A; Adolfsson R; Aquilonius SM; Gottfries CG; Oreland L; Svennerholm L; Winblad B
Adv Biochem Psychopharmacol; 1980; 23():295-304. PubMed ID: 6156586
[TBL] [Abstract][Full Text] [Related]
31. Progressive supranuclear palsy and corticobasal degeneration.
Litvan I
Baillieres Clin Neurol; 1997 Apr; 6(1):167-85. PubMed ID: 9426874
[TBL] [Abstract][Full Text] [Related]
32. [125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys.
Villares J; Faucheux B; Herrero MT; Obeso JA; Duyckaerts C; Hauw JJ; Agid Y; Hirsch EC
Exp Neurol; 1998 Nov; 154(1):146-56. PubMed ID: 9875276
[TBL] [Abstract][Full Text] [Related]
33. Neurotransmitter receptor binding: regional distribution in human brain.
Enna SJ; Bennett JP; Bylund DB; Creese I; Burt DR; Charness ME; Yamamura HI; Simantov R; Snyder SH
J Neurochem; 1977 Jan; 28(1):233-6. PubMed ID: 13155
[No Abstract] [Full Text] [Related]
34. [Effect of monocrotophos on the neurotransmitter system in the central nervous system].
Borkowska J; Tyburczyk W
Rocz Panstw Zakl Hig; 1980; 31(6):605-10. PubMed ID: 6114558
[No Abstract] [Full Text] [Related]
35. Significance of neurotransmitter abnormalities in Alzheimer's disease.
Katzman R; Brown T; Fuld P; Thal L; Davies P; Terry R
Res Publ Assoc Res Nerv Ment Dis; 1986; 64():279-86. PubMed ID: 2873637
[No Abstract] [Full Text] [Related]
36. Radiation-induced changes in the activity of brain enzymes involved in neurotransmitter metabolism.
Catravas GN; McHale CG
Radiat Res; 1974 Jun; 58(3):462-9. PubMed ID: 10876636
[No Abstract] [Full Text] [Related]
37. Discrete regional distribution of biochemical markers for the dopamine, noradrenaline, serotonin, GABA and acetylcholine systems in the monkey brain (Cebus Apella). Effects of stress.
Häggström JE; Sjöquist B; Eckernäs SA; Ingvast A; Gunne LM
Acta Physiol Scand Suppl; 1984; 534():1-27. PubMed ID: 6150601
[TBL] [Abstract][Full Text] [Related]
38. [A biochemical theory of schizophrenia].
Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
[TBL] [Abstract][Full Text] [Related]
39. [Neurochemical pathology of GABAergic and cholinergic systems in Parkinson disease: an autopsy study].
Nishino N; Hanada S; Mita T; Fujiwara H; Tanaka C; Noguchi-Kuno SA; Ichikawa K
Rinsho Shinkeigaku; 1984 Nov; 24(11):1079-85. PubMed ID: 6097387
[No Abstract] [Full Text] [Related]
40. [Enzymatic methods for the identification of a transmitter substance in a specific brain nucleus (author's transl)].
Kataoka K; Sorimachi M
Tanpakushitsu Kakusan Koso; 1974 Jul; 19(7):537-49. PubMed ID: 4154482
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
